Mike Snape, the Chief Scientific Officer at Autism Therapeutics Ltd. and member of the ICare4Autism Advisory Council will be speaking on Autism in Israel at the upcoming August Autism Conference held by ICare4Autism. More specifically, Dr. Snape’s address will over topics of pharmaceuticals used to treat all disorders on the autistic spectrum including Fragile X. [...]
Connect with ICare4Autism
News








